Oramorph Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in Description.
Diarrhoea caused by poisoning.
Acute respiratory insufficiency or respiratory depression, obstructive airways disease.
Concurrent administration with monoamine oxidase (MAO) inhibitors or within 2 weeks of Discontinuation of treatment with MAO (see Interactions).
The risk-benefit of morphine use should be evaluated when the following medical problems are present: Acute abdomen; Asthma attacks and acute and severe bronchial obstruction; Cardiac arrhythmias; History of convulsions (see Precautions); Acute alcohol intoxication; Agitation in patients secondary to use of alcohol or hypnotics, emotional instability, suicidal ideation; Head injury and conditions with increased intracranial pressure; Acute liver disorders (hepatitis, hepatic porphyria); Paralytic ileus; Coma; Patients with phaeochromocytoma. Morphine and some other opioids can induce the release of endogenous histamine and thereby stimulate catecholamine release; Pregnancy and lactation (see Use in Pregnancy & Lactation).